Professional and Reliable IHC Raw Antibody Solutions for Myositis Pathology
Myositis pathology often requires assessment of inflammatory cell infiltration, muscle fiber damage, and vascular changes. AREX provides high-quality IHC raw antibodies supporting detection of immune cell markers and muscle-related targets to optimize diagnostic and classification solutions for inflammatory myopathies.
Core Advantages:
High specificity and low background suited to the inflammatory staining environment of muscle tissue
Good sensitivity meeting needs across varying degrees of inflammation
Excellent batch-to-batch consistency for R&D to large-scale OEM supply
AREX myositis pathology raw antibodies integrate seamlessly with our
ARExVisual® micropolymer detection system and
Ancillaries supporting reagents to deliver a complete IHC solution.
Contact us to request catalogs, sample testing, or technical consultation.